Abstract
Hypertrophic cardiomyopathy is a heterogenous condition associated with a myriad of symptoms. Just as in other disease states, the aim of medical therapy is the alleviation of suffering, improvement of longevity, and the prevention of complications. This article focuses on the associated comorbidities seen in patients with hypertrophic cardiomyopathy, potential lifestyle interventions, and conventional medical treatments for symptomatic hypertrophic cardiomyopathy.
Original language | English (US) |
---|---|
Pages (from-to) | 45-54 |
Number of pages | 10 |
Journal | Cardiology Clinics |
Volume | 37 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2019 |
Keywords
- Beta-blocker
- Calcium channel blocker
- Cardiomyopathy
- Disopyramide
- Hypertrophic
- Lifestyle
- Obstruction
- Ranolizine
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine